We are extremely excited and thankful to the American Cancer Society and the Harper Cancer Research Institute for facilitating this seed grant for our work on label-free targeting of undruggable cancer cells. We intend to target non-targetable cancer cells by tuning the force exerted by label-free nanomaterials at the cell membrane to selectively permeabilize the …
Category Archive: chemotherapeutics
Feb 14
American Cancer Society Seed Grant Awarded to us to Develop a Label-Free, Precise Chemotherapeutic Delivery to Metastatic Breast Cancer Cells In Vivo
Categories:
AD&T Notre Dame, American Cancer Society, Berthiaume Institute for Precision Health, chemotherapeutics, Harper Cancer Research Institute, Label-free, magnetoelectrics, metastatic cancer cells
by Prakash
Tags: NDNano
Recent Posts
- AY 2026 in Review: PD[N]ano Lab Highlights Featured in the Provost’s TPAC-RL May 2026 Newsletter May 9, 2026
- Aurelie Brownsberger Leads a Student Cohort in a Journal of Nanotheranostics Invited Feature Review on Intrinsically Selective Therapeutic Nanoplatforms May 9, 2026
- Lab Family Dinner 2026: Celebrating Our Team and Sending Off Our Graduating Seniors April 28, 2026
- Pitching MagSiNs at the IDEA Center’s Inaugural Research Commercialization Grant Event April 24, 2026
- From the Bench to the Big Picture: Kendall Bradley Earns ACS Honors at the 2026 Hoosier Science and Engineering State Fair and Returns to the Lab for Senior Year! April 20, 2026
Archives
Categories
NIH Funding Opportunities
- Notice to Rescind NOT-HL-24-008 "NHLBI Announces New Policies Regarding Budget Guidelines for SBIR/STTR Applications" May 13, 2026Notice NOT-HL-26-005 from the NIH Guide for Grants and Contracts
- Notice of Early Expiration of PAR-25-202 "Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)" May 12, 2026Notice NOT-GM-26-005 from the NIH Guide for Grants and Contracts

Recent Comments